Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 for Obesity on Monday, December 8, 2025
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
Nextech3D.ai Closes Krafty Labs Acquisition Expanding into a Comprehensive End-to-End AI-Powered Live Events and Experiential Engagement Platform
LaFleur Minerals Closes LIFE, Flow Thru and Final Hard Dollar Offering for $900,000 to Complete Total of $7,800,421 Funding to Restart Beacon Gold Mill Production Operations in Abitibi Greenstone Belt
RZOLV Technologies Successfully Completes Bulk-Scale Vat Leach Test at Operating Gold Mine, Advancing Commercial Validation of RZOLV Non-Cyanide Gold Extraction
TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY'S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS
